Waiting times for radiotherapy: Consequences of volume increase for the TCP in oropharyngeal carcinoma

Radiotherapy and Oncology

Volumn 66, Issue 3, 2003, Pages 271-276

  Waaijer, Annet ^a   Terhaard, Chris H J ^a   Dehnad, Human ^a   Hordijk, Gerrit Jan ^b   Van Leeuwen, Maarten S ^a   Raaymakers, Cornelius P J ^a   Lagendijk, Jan J W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Dept Radiother of the UMC Utrecht ^*  (Netherlands)

Author keywords

Oropharyngeal carcinoma; Radiotherapy; TCP; Tumour growth; Waiting time

Indexed keywords

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; CALCULATION; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EVALUATION; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; MALE; MEASUREMENT; OROPHARYNX; OROPHARYNX CANCER; OROPHARYNX TUMOR; PATHOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROBABILITY; RADIOGRAPHY; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; TIME; TOMOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH; TUMOR VOLUME;

EID: 0038061625     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00036-7     Document Type: Article

References (21)

1. Brouha X.D.R., Op de Coul B., Terhaard C.J.H., Hordijk G. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol. 25:2000;215-218.
2. Dubben H.H., Thames H.D., Beck-Bornhold H.P. Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol. 47:1998;167-174.
3. Edwards B.K., Howe H.L., Ries L.A.G., et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 94:2002;2766-2792.
4. Fortin A., Bairati I., Albert M., Moore L., Allard J.B.A., Couture C. Effect of treatment delay on outcome of patients with early stage head and neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 52:2002;929-936.
5. Gilbert R.W., Shulman H., MacKenzie R., et al. Correlation of tumour volume with local control in laryngeal carcinoma treated by radiotherapy. Ann Otol Laryngol. 96:1987;514-518.
6. Grabenbauer G.G., Steininger H., Meyer M., et al. Nodal density and total tumour volume as prognostic factors after radiation therapy of stage 3/4 head and neck cancer. Radiother Oncol. 47:1998;175-183.
7. Hall E.J. Time, dose and fractionation in radiotherapy. Hall E.J. 5th ed. Radiobiology for the radiologist. 2000;397-415 JP Lippincott, Philadelphia.
8. Hermans R., Op de Beeck K., Van den Bogaert W., et al. The relation of CT-determined tumour parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys. 50:2001;37-45.
9. Johnson C.R., Khandelwal S.R., Schmidt-Ullrich R.K., Ravalese J., Wazer D.E. The influence of quantitative tumour volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys. 32:1998;635-664.
10. Lee W.R., Mancuso A.A., Saleh E.M., Mendenhall W.M., Parsons J.T., Million R.R. Can pre-treatment CT findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone? Int J Oncol Biol Phys. 25:1993;683-687.
11. Mackillop W.J., Bates J.H., O'Sullivan B., Withers H.R. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 34:1996;243-250.
12. Mackillop W.J., Fu H., Quirt C.F., Dixon P., Brundage M., Zhou Y. Waiting time for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 30:1994;221-228.
13. Mackillop W.J., Zhou Y., Quirt C.F. A comparison of delays in the treatment of cancer with radiation in Canada and the United States. Int J Radiat Oncol Biol Phys. 32:1995;531-539.
14. De Meerleer G.O., Vakaet L.A.M.L., Gersem W.R.T., De Wagter C., De Naeyer B., Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys. 47:2000;639-648.
15. Nathu R.M., Mancuso A.A., Zhu T.C., Mendenhall W.M. The impact of primary tumour volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck. 22:2000;1-5.
16. Nederveen A.J., Heide U.A., Hofman P., Welleweerd H., Lagendijk J.J.W. Partial boosting of prostate tumours. Radiother Oncol. 61:2001;117-126.
17. Nutting C.M., Corbishley C.M., Sanchez-Nieto B., Cosgrove V.P., Webb S., Dearnaley D.P. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol. 75:2002;151-161.
18. O'Rourke N., Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol. 12:2000;141-144.
19. Radiotherapie: onze zorg. Actualisatierapport van de Nederlandse Vereniging voor Radiotherapie en Oncologie. Utrecht maart 2000.
20. 5th. 5th ed. 5th. 1997;Wiley-Liss, New York.
21. Webb S., Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 38:1993;653-666.